The Inflation Reduction Act (IRA) is now law. Some key provisions found in the bill are already being implemented—with more coming around the corner. Uncertainty is high, but many organizations are already acting to limit their anticipated exposure. What do organizations need to know and how should they adjust plans given the law’s different impacts in different circumstances?


In this webinar, a team of industry experts talk about the latest IRA developments and what biopharma should be doing to stay ahead of the curve.


During this webinar, we also discuss:

  • The current state of play and major market events
  • Operational and tactical planning in the near term
  • Pipeline and portfolio planning and strategy in the medium and long term